PRSS50 and hepatocellular carcinoma: We indeed found that TSP50 maintained low PKM2 pyruvate kinase activity in TSP50-transfected L02 cells and this was also demonstrated by the enhanced pyruvate kinase activity of PKM2 in TSP50 knock-downed HCC cells.